Sionna Therapeutics, Inc. (SION)
NASDAQ · Healthcare
$45.69-7.53%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.04B
- P/E ratio
- —
- EPS
- —
- Volume
- 800,169
- 52-week high
- —
- 52-week low
- —
- Open
- $50.20
- Day high
- $51.29
- Day low
- $44.78
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$75.27M | -$1.88 |
| 2024 | — | -$61.69M | -$15.99 |
About Sionna Therapeutics, Inc.
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
- CEO
- Michael Cloonan
- Employees
- 59
- Country
- US
- IPO date
- Feb 7, 2025
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Sionna Therapeutics, Inc.'s stock price today?
- SION is trading at $45.69 as of Jul 20, 2026.
- What is Sionna Therapeutics, Inc.'s market cap?
- Sionna Therapeutics, Inc. (SION) has a market capitalization of $2.04B.
- Does Sionna Therapeutics, Inc. pay a dividend?
- Sionna Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Sionna Therapeutics, Inc. in?
- Sionna Therapeutics, Inc. operates in the Healthcare sector.